o2h ventures
To add a bio or update investment portfolio, please click update information.
Investment Portfolio
Monument Therapeutics
25 Feb 2025
Monument Therapeutics secures £850k led by ACF Investors to advance schizophrenia treatment with MT1988
Monument Therapeutics applies digital biomarkers to psychiatric drug development, advancing combination therapies designed to improve cognitive impairment in schizophrenia alongside existing antipsychotic treatments.
Atelerix
28 Jan 2025
Atelerix lands £750k from ACF Investors and o2h ventures to revolutionise biological transport
Atelerix develops hydrogel technology that allows biological samples to be stored and shipped at ambient temperatures while maintaining cell viability.
o2h ventures
More venture news
- 17 Mar 2026
Sequential BioSequential secures £2.6m in funding led by Sparkfood and Corundum Systems Biology for non-invasive testing of skin health ingredients
EquityLife Sciences - 10 Mar 2026
DealFlowAgentDealFlowAgent raises £570k in funding led by Long Journey for M&A platform for SME firms
EquityEnterprise - 10 Mar 2026
AvvokaAvvoka secures £14m in funding from Valhalla Ventures for legal drafting software platform
EquityLegal